Hot topic

A cost-effectiveness analysis of nivolumab versus docetaxel for advanced non-squamous non-small cell lung cancer including PD-L1 testing.

Matter-Walstra K, Schwenkglenks M, Aebi S, Dedes K, Diebold J, Pietrini M, Klingbiel D, von Moos R, Gautschi O; SAKK.

J Thorac Oncol. 2016 Jun 13. pii: S1556-0864(16)30507-X. doi: 10.1016/j.jtho.2016.05.032. [Epub ahead of print]

Kommentar schreiben

Kommentare: 0

Fr

16

Apr

2021

Vorbereitungen R├╗zje Wyn 2021

Sa

24

Okt

2020

Kroatien 2020

Sa

23

Mai

2020

Arc-en-ciel

Thanks to Saskia and Patrick for these recordings

mehr lesen

Sa

21

Dez

2019

Newest Publication

Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study.

Panje CM, Putora PM, Hundsberger T, Hottinger AF, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K.

Swiss Med Wkly. 2019 Dec 2;149:w20153. doi: 10.4414/smw.2019.20153. eCollection 2019 Dec 2.